4/A
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-020056
Director acquired 1,231 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hernday Natasha Director | 2024-07-19 | Grant or award | +1,231 | 6,231 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hernday Natasha Director | 2024-07-19 | Grant or award · Stock Option (Right to Buy) | +4,111 | 4,111 | D: show line 2 in the form |
Loading xslF345X05/form4a-07242024_080702.xml…